Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis

Emmanouil Galanakis1, Maria Bitsori, Helen Dimitriou

  • 1Department of Pediatrics, University Hospital of Heraklion, Heraklion, Greece.

Insights

Interleukin-6 (IL-6) is implicated in early pyelonephritis in infants, as indicated by elevated urine IL-6 levels. Transforming growth factor-beta1 (TGF-beta1) does not appear to play a significant role in the acute phase of this infection.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Cytokines are crucial in the acute response to pyelonephritis and subsequent renal scarring.
  • Assessing pro-inflammatory (IL-6) and anti-inflammatory/pro-fibrotic (TGF-beta1) cytokines is important in young infants with pyelonephritis.

Purpose of the Study:

  • To evaluate serum and urine concentrations of IL-6 and TGF-beta1 in infants with pyelonephritis.
  • To understand the role of these cytokines in the early pathogenesis of pyelonephritis in neonates and young infants.

Main Methods:

  • Serum and urine samples collected from infants with pyelonephritis and non-renal fever.
  • Enzyme immunoassay used to quantify IL-6 and TGF-beta1 concentrations.
  • Comparison of cytokine levels between pyelonephritis patients and control groups.

Main Results:

  • No significant difference in serum IL-6 or TGF-beta1 between pyelonephritis infants and controls.
  • Significantly higher urine IL-6 levels observed in infants with pyelonephritis compared to controls (P=0.0106).
  • Urine TGF-beta1 levels were lower in pyelonephritis infants, but this difference was not statistically significant (P=0.0705).

Conclusions:

  • IL-6 is confirmed to be involved in the early stages of pyelonephritis pathogenesis in young infants.
  • TGF-beta1 does not appear to be significantly involved in the acute phase of pyelonephritis.
  • Further research is needed to clarify the role of TGF-beta1 in the development of renal scarring associated with pyelonephritis.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.